New Enterprise Associates 15, L.P.'s Net Worth

$810 Million

Estimate Recalculated Feb 22, 2024 11:13AM EST

Who is New Enterprise Associates 15, L.P.?

New Enterprise Associates 15, L.P. has an estimated net worth of $810 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., AVEO PHARMACEUTICALS, INC., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.

SEC CIK

New Enterprise Associates 15, L.P.'s CIK is 0001629794

Past Insider Trading and Trends

2018 was New Enterprise Associates 15, L.P.'s most active year for acquiring shares with 26 total transactions. New Enterprise Associates 15, L.P.'s most active month to acquire stocks was the month of July. 2021 was New Enterprise Associates 15, L.P.'s most active year for disposing of shares, totalling 22 transactions. New Enterprise Associates 15, L.P.'s most active month to dispose stocks was the month of July. 2021 saw New Enterprise Associates 15, L.P. paying a total of $87,118,710.00 for 208,338,857 shares, this is the most they've acquired in one year. In 2019 New Enterprise Associates 15, L.P. cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Berkshire Grey, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-38.18M
0
Jul 20
Form 3
0
0
No matching records found

Nightstar Therapeutics plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.66M
$25.50
-$169,894,566.00
0
Jun 7
Form 3
0
0
No matching records found

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.79M
$15.00
4.79M
Apr 13
Form 3
0
0
No matching records found

Arcellx, Inc. (ACLX) Snapshot price: $64.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-29.65%
-2.00M
4.75M
Dec 20
Form 4
+4.86%
312.5K
$16.00
$5,000,000.00
6.75M
Jun 21
Form 4
6.43M
$15.00
$23,749,995.00
6.43M
Feb 8
Form 3
0
0
No matching records found

IonQ, Inc. (IONQ) Snapshot price: $10.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-44.44%
-11.69M
14.61M
Nov 16
Form 4
-10.00%
-2.92M
$5.84
-$17,073,458.62
26.31M
May 26 - May 31
Form 3
0
0
No matching records found